Récipiendaires de la Bourse de recherche cardiovasculaire SCC-Bayer
2022
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
Ping Yu Xiong | Investigating the Metabolomic Profile of Transplanted Heart with and without Pathological Signs of Rejection | 20 000 $ |
Kevin J. Um | DiastologY-Guided MaNAgement of DecoMpensated Heart Failure – A Pilot RandomIzed, Controlled Trial (DYNAMIC) | 15 000 $ + 5 000 $ de prime de présentation |
Kevin R. An | Long-term Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Women with Severe Coronary Artery Disease | 10 000 $ |
2021
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
Rachel Eikelboom | Subclinical Valve Thrombosis in Patients with Surgical Bioprosthetic Valve Replacements: An Imaging Pilot Substudy of the DANCE Trial | 20 000 $ + 5 000 $ de prime de présentation |
Haya Aziz | Sex-related Differences in Biomarkers in Patients with Diabetes Mellitus Post Myocardial Infarction-II | 15 000 $ |
Spencer Lalonde | Medication Optimization in the Heart Failure Clinic and the Impact on Left Ventricular Ejection Fraction: An Analysis of Recently Diagnosed Heart Failure Patients Followed at a Tertiary Centre | 10 000 $ |
2020
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
Pishoy Gouda | Rivaroxaban with Aspirin in Type 2 Myocardial Infarctions: A Feasibility, Open-label, Randomized Controlled Trial | 20 000 $ |
Anna Zavodni | A Novel Method of Hemolysis and Thrombosis Detection Utilizing Surface-Enhanced Raman Spectroscopy | 15 000 $ |
Maxime Robert-Halabi | Optimal Utilization of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease | 10 000 $ + 5 000 $ de prime de présentation |
2019
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Pietro Di Santo | Direct Oral Anticoagulation Post-Transradial Access for the Prevention of Radial Artery Occlusion | 20 000 $ |
| Pishoy Gouda | An Externally Validated Prediction Tool for Peripheral Arterial Disease in Patient with Documented Coronary Artery Disease | 15 000 $ |
| Alice Chang | Beyond Atrial Fibrillation: Using Artificial Intelligence, Big Data and Imaging to Improve Stroke Risk Assessment and Management | 10 000 $ + 5 000 $ de prime de présentation |
2018
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Ali Alsagheir | Low INR to Minimize Bleeding with Mechanical Valves Trial (LIMIT) Pilot | 20 000 $ |
| Jari M. Tuomi | Ibrutnib, Dose Dependently, Promotes Atrial Fibrillation in Mice by Depressing Cardiac Conduction | 15 000 $ + 5 000 $ de prime de présentation |
2017
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Thomas M. Roston | Cardiac RyAnodinereceptor Variants in Early-onset Atrial Fibrillation: The CRAVE-AF Study | 20 000 $ + 5 000 $ de prime de présentation |
| Michael Chiu | Heat Shock Protein 27: A Potential Biomarker for Atrial Fibrillation | 12 500 $ |
| Amine Mazine | A Pilot Echocardiographic and CT Imaging Study to Evaluate Subclinical Leaflet Thrombosis Following Surgical Bioprosthetic Aortic Valve Replacement | 7 500 $ |
2016
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Christopher Cheung | Does Intensive Monitoring Improve Diagnosis and Treatment of Atrial Fibrillation after Myocardial Infarction? | 20 000 $ + 10 000 $ de prime de présentation |
| Derrick Tam | Improving Outcomes in Cardiac Surgery through Reduction in Readmission: A Novel Risk Stratification Tool | 12 500 $ |
| Tina Zhu | Carotid Contrast-Enhanced Ultrasound (CEUS) as a Risk Stratification Tool for Cardiovascular Disease | 7 500 $ |
2015
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| William F. McIntyre | Atrial Fibrillation Occurring Transiently with Stress (AFOTS) Understanding the Risks of Subsequent AF and Stroke | 20 000 $ + 5 000 $ de prime de présentation |
| Saman Rezazadeh | Automated Reminder to Initiate Oral Anticoagulation in Patients with Atrial Fibrillation/Atrial Flutter Discharged Directly From the Emergency Department: REMINDER STUDY | 12 500 $ |
| Hadi Toeg | Hybrid Coronary Revascularization in Diabetics (HYCARDS) Randomized | 7 500 $ |
2014
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Guillaume Marquis Gravel | The Bromocriptine in Heart Failure (BRO-HF) Initiative | 20 000 $ + 5 000 $ de prime de présentation |
| Iqbal H. Jaffer | Prevention of Clotting on Mechanical Heart Valves | 12 500 $ |
| Abhinav Sharma | In Patients with Heart Failure, Does Diabetic Status Influence Clinical Outcomes? | 7 500 $ |